“The release of immunoreactive secretin was increased dose-dependently over the control by dibutyryl cyclic-3′, 5′-adenosine monophosphate, forskolin , 4β-12-O-tetradecanoylphorbol-13-acetate, the synthetic serine protease inhibitor, camostat, and the calcium ionophore, A23187.”